A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

The company saw its DNA data as an engine that would revolutionize drug discovery and medical care, but it never found a ...

Many 23andMe customers signed up to the genetic testing service in hopes of learning fun or interesting information about their past. But consumer advocates are now urging those users to request the ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...

The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...

Me was once the darling of postbox DNA testing, but after a colossal data breach and months of business turmoil, the company ...

Me's drugs and patents — including two possible deals — could be key to its exit out of Chapter 11 bankruptcy protection.

And now the company is heading into bankruptcy protection, raising concerns about privacy, potential government access to the data and the company’s future business practices under new owners. Should ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. The company said Sunday that ...